VIRO logo

ViroGates A/S Stock Price

CPSE:VIRO Community·DKK 88.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

VIRO Share Price Performance

DKK 9.55
-0.50 (-4.98%)
DKK 9.55
-0.50 (-4.98%)
Price DKK 9.55

VIRO Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with slight risk.

4 Risks
1 Reward

ViroGates A/S Key Details

DKK 9.0m

Revenue

DKK 1.9m

Cost of Revenue

DKK 7.1m

Gross Profit

DKK 17.3m

Other Expenses

-DKK 10.2m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 20, 2026
-1.10
78.46%
-113.54%
25.1%
View Full Analysis

About VIRO

Founded
2000
Employees
7
CEO
Jakob Knudsen
WebsiteView website
www.virogates.com

ViroGates A/S, an in vitro diagnostics company, develops and sells blood tests for measuring chronic inflammation for the healthcare sector. It offers suPARnostic TurbiLatex, a CE-IVD approved particle-enhanced turbidimetric immunoassay for quantitative measurement of suPAR in human plasma; suPARnostic AUTO Flex ELISA kit, a fully quantitative immunoassay designed for accurate and reliable measurement of soluble urokinase plasminogen activator receptor in human plasma; and suPARnostic Quick Triage, a test for rapid, quantitative measurement of suPAR levels. ViroGates A/S was founded in 2000 and is headquartered in Birkerød, Denmark.

Recent VIRO News & Updates

Recent updates

No updates